Stem Cells, Vol 13, 453-461, Copyright © 1995 by AlphaMed Press

REVIEWS

The contribution of marker gene studies to hemopoietic stem cell therapies

MK Brenner
Division of Bone Marrow Transplantation, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Although the transfer of "therapeutic" genes into hemopoietic stem cells (HSC) offers many opportunities to treat a wide range of human disease, the low efficiency of transfer and limited expression of the transferred gene have so far largely prevented any direct beneficial effect from being obtained. However, gene marker studies in which the transferred genes are used simply to track the individual components of the infused HSC have already shown their utility. Genetic marking may be used to identify cells capable of causing relapse after autologous bone marrow transplantation and to distinguish cells in the graft capable of preventing malignant disease. Marking may also be used to analyze the consequences of ex vivo or in vivo manipulations of the HSC which are intended to accelerate engraftment or augment gene transfer efficiencies. Information obtained from these studies should therefore not only improve the outcome of HSC based therapies, but also aid in the introduction of successful gene therapy protocols.

This article has been cited by other articles:

				K. Branson, R. Chopra, P. D. Kottaridis, G. McQuaker, A. Parker, S. Schey, R. K. Chakraverty, C. Craddock, D. W. Milligan, R. Pettengell, et al. Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies J. Clin. Oncol., October 1, 2002; 20(19): 4022 - 4031. [Abstract] [Full Text] [PDF]

				J. A Smith and B. R Goldspiel Cancer gene therapy update Journal of Oncology Pharmacy Practice, March 1, 1999; 5(1): 7 - 21. [Abstract] [PDF]

				P. B. van Hennik, M. M.A. Verstegen, M. F.A. Bierhuizen, A. Limon, A. W. Wognum, J. A. Cancelas, J. Barquinero, R. E. Ploemacher, and G. Wagemaker Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient Mice Blood, December 1, 1998; 92(11): 4013 - 4022. [Abstract] [Full Text] [PDF]

				M. F.A. Bierhuizen, Y. Westerman, T. P. Visser, W. Dimjati, A. W. Wognum, and G. Wagemaker Enhanced Green Fluorescent Protein as Selectable Marker of Retroviral-Mediated Gene Transfer in Immature Hematopoietic Bone Marrow Cells Blood, November 1, 1997; 90(9): 3304 - 3315. [Abstract] [Full Text] [PDF]

				R.V.B. Emmons, S. Doren, J. Zujewski, M. Cottler-Fox, C.S. Carter, K. Hines, J.A. O'Shaughnessy, S.F. Leitman, J.J. Greenblatt, K. Cowan, et al. Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34+ Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo Blood, June 1, 1997; 89(11): 4040 - 4046. [Abstract] [Full Text] [PDF]